Lipid rafts, dopamine 1 receptor, and hypertension
Lipid rafts, dopamine 1 receptor, and hypertension
批准号:
10544330
负责人:
Pedro A. Jose
金额:
$64.24万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-09 至 2023-12-31
关键词:
ADRBK1 geneAdenylate CyclaseAgonistAlbuminuriaBackBiologicalBlood PressureC57BL/6 MouseCaucasiansCell membraneCellsCyclic AMPCyclic AMP-Dependent Protein KinasesDRD1 geneDataDietDopamineDopamine D1 ReceptorEast AsianEssential HypertensionEthnic OriginExcretory functionFamilyG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGene FrequencyGenesGenetic PolymorphismGolgi ApparatusHaplotypesHumanHypertensionImpairmentKidneyKnowledgeMaintenanceMediatingMembraneMembrane MicrodomainsMinorMolecularMusMutateMutationN-ethylmaleimide-sensitive proteinNADPH OxidasePalmitic Acylation SiteParaoxonase-2Pathway interactionsPhosphorylationPlasmaPlasma CellsPopulationProductionProtein DephosphorylationProtein phosphataseProteinsProximal Kidney TubulesRattusReactive Oxygen SpeciesReceptor InhibitionRecyclingRegulationRenal tubule structureRodentScaffolding ProteinSodium ChlorideSortingTestingVariantZinc Fingersantioxidant enzymeblood pressure elevationblood pressure regulationdesensitizationgenetic variantglycosylationhigh salt diethypertensivemutantnormotensivepalmitoylationpharmacologicpreventreceptorreceptor expressionreceptor functionreceptor-mediated signalingresponsesalt sensitive hypertensionsorting nexinstrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The D1 dopamine receptor (D1R) is important in the regulation of blood pressure (BP). Drd1
germline deletion in mice causes hypertension. G protein-coupled receptor kinase type 4
(GRK4) is important in the normal cellular recycling and function of D1R. However, some of the
recycled D1R has to be targeted to lipid rafts to be functional. Thus, mutant D1Rs 347C>A and
351C>A still target to the plasma membrane but fail to localize in lipid rafts; these mutations
prevent the increase in D1R-mediated stimulation of cAMP production in renal proximal tubule
cells (RPTCs) and impair (e.g., 347C>A) normal BP regulation in mice. C347 and C351 in D1R
are palmitoylation sites; SNX19 functions as a scaffold protein for the palmitoylation of D1R at
the Golgi, via Golgi-specific zinc finger protein. Lipid rafts are also needed for the proper
membrane distribution and maintenance of adenylyl cyclases 5 and 6 and regulation by D1R.
Inhibition or molecular biological disruption of palmitoylation prevents D1R targeting to lipid rafts,
impairs D1R function, and causes hypertension. Silencing SNX19 impairs D1R-mediated
increase in cAMP and decrease in Na+ transport in RPTCs but not distal convoluted tubule cells.
Renal SNX19 is important in the regulation of BP; renal-restricted silencing of Snx19 increases
BP in C57Bl/6 mice on normal but not low salt diet. Germline deletion of SNX19 in mice also
increases BP on normal salt diet. SNX19 is upstream of D1R. SNX19 rs2298566 is associated
with decreased ability to excrete Na+ and high BP in humans and impairs D1R function in human
(h)RPTCs. SNX19 protein is decreased in hRPTCs from hypertensive humans. We will test the
overall hypothesis that SNX19 is important in the trafficking of D1R to lipid rafts in the RPT
plasma membrane for normal D1R function. Impaired functioning of D1R in the kidney, caused
by its impaired trafficking to lipid rafts in RPT plasma membranes, causes salt-sensitive
hypertension. Specific Aim 1 will test the hypothesis that SNX19 targeting of D1R into the lipid
rafts of RPTC plasma membrane is crucial for normal D1R function. SNX19 and GRK4 interact
in lipid rafts to regulate D1R function, including D1R-mediated inhibition of Na+ transport in
RPTCs. Specific aim 2 will test the hypothesis that mutations of the palmitoylation sites in the
D1R gene prevent the ability of SNX19 to target the D1R to lipid rafts in the RPTC plasma
membrane. Germline deletion or renal-restricted deletion of SNX19 in C57Bl/6 mice causes salt-
sensitive hypertension. Mutating DRD1 to prevent D1R targeting to lipid rafts of RPTC plasma
membrane also causes salt-sensitive hypertension. These genes and their proteins could be
targets in the treatment of human essential hypertension.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bbrc.2021.07.071
发表时间:
2021-10-01
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Ashraf UM, Mell B, Jose PA, Kumarasamy S]
通讯作者:
Kumarasamy S
DOI:
10.1161/jaha.120.019365
发表时间:
2021-04-06
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[Kundu N, Nandula SR, Asico LD, Fakhri M, Banerjee J, Jose PA, Sen S]
通讯作者:
Sen S
D2 receptor variation and renal dysfunction
-
批准号:10564943
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2023
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:9886774
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10083735
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10319571
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Ds receptor antioxidant activity and hypertension
-
批准号:8148031
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2010
-
负责人:Pedro A. Jose
-
依托单位:
Dopamine-1 Receptor Defect in Hypertension
-
批准号:7921095
-
项目类别:
-
资助金额:$17.2万
-
财政年份:2009
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8123257
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7658921
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7908700
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8266339
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
D5 Receptor Antioxidant Activity and Hypertension
-
批准号:7218286
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2006
-
负责人:Pedro A. Jose
-
依托单位:
Animal models of salt sensitivity: roles of GRK4 and sodium transporters on salt sensitivity
-
批准号:9283600
-
项目类别:
-
资助金额:$74.68万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and D3R regulation of NHE3 and NCC expression
-
批准号:7778674
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
D3, D1, AT1 Receptor Interaction--Genetic Hypertension
-
批准号:6781667
-
项目类别:
-
资助金额:$56.36万
-
财政年份:2003
-
负责人:Pedro A. Jose
-
依托单位:
D5 receptor antioxidant activity and hypertension
-
批准号:6656540
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2002
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6346138
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2000
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6201931
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1999
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6105772
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1998
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:6043980
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:2372962
-
项目类别:
-
资助金额:$21.01万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
海外基金